During the most recent trading session, Gilead Sciences, Inc. (NASDAQ:GILD) shares traded +0.5590%. Tracking the stock price in relation to moving averages may provide enhanced perspective on stock performance. After a recent look, the stock has been seen trading $1.1876 off of the 50-day moving average of $67.3031 and $-2.8311 separated from the 200-day moving average of $71.3218. Taking a further look from a different perspective, the stock has been recently recorded -23.1478% off of the 52-week high of 89.1200 and +4.7579% apart from the 52-week low of 65.3800. Monitoring stock price activity relative to moving averages and the highs and lows for the past year might help with future stock price value assessment.
Price Target in Focus
While monitoring stock technicals is important, most investors are more concerned with where the stock might be going now. Equity research analysts have provided views on where they believe the stock will be trading in the future. According to Thomson Reuters, sell-side analysts are projecting a consensus target price of $78.9200 on company shares. This is a near-term estimate for the next 12-18 months.
Currently, Gilead Sciences, Inc. has a price to earnings ratio of 6.8904. Analysts and investors may also opt to evaluate a company's PEG or price to earnings growth ratio. The stock currently has a PEG Ratio of -1.7600.
According to data provided by Zacks Research, UnitedHealth Group Incorporated (NYSE:UNH) has a consensus target price of $183.875 on the stock. Out of the polled analysts providing targets, the high is currently $210, while the low is resting at $145. Analyst price targets may vary depending on the individual method used to calculate the estimate.
Turning to earnings, analysts are expecting UnitedHealth Group Incorporated (NYSE:UNH) to post a current quarter EPS of $2.38. This consensus number is compiled by Zacks Research. For the period ending on 2017-03-31, the company reported EPS for the quarter of $2.37. The resulting surprise factor from the difference between the reported number and the consensus estimate going into earnings was 8.72%. After a company reports earnings, the stock may see increased activity. The next earnings report date is scheduled on or near 2017-07-18.
In terms of analyst ratings, UnitedHealth Group Incorporated (NYSE:UNH) has a current ABR of 1.28. This average broker recommendation is given by Zacks using a scale from 1 to 5. According to this scale, a rating of 1 or 2 would indicate a Buy, and a rating of 4 or 5 would signify a Sell recommendation. A 3 would indicate a Hold on the stock.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.